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A B S T R A C T
White matter hyperintensities (WMH) are frequently divided into periventricular (PWMH) and deep (DWMH),
and the two classes have been associated with different cognitive, microstructural, and clinical correlates.
However, although this distinction is widely used in visual ratings scales, how to best anatomically define the
two classes is still disputed. In fact, the methods used to define PWMH and DWMH vary significantly between
studies, making results difficult to compare. The purpose of this study was twofold: first, to compare four
current criteria used to define PWMH and DWMH in a cohort of healthy older adults (mean age: 69.58 ± 5.33
years) by quantifying possible differences in terms of estimated volumes; second, to explore associations
between the two WMH sub-classes with cognition, tissue microstructure and cardiovascular risk factors,
analysing the impact of different criteria on the specific associations. Our results suggest that the classification
criterion used for the definition of PWMH and DWMH should not be considered a major obstacle for the
comparison of different studies. We observed that higher PWMH load is associated with reduced cognitive
function, higher mean arterial pressure and age. Higher DWMH load is associated with higher body mass index.
PWMH have lower fractional anisotropy than DWMH, which also have more heterogeneous microstructure.
These findings support the hypothesis that PWMH and DWMH are different entities and that their distinction
can provide useful information about healthy and pathological aging processes.
Introduction
White matter hyperintensities of presumed vascular origin (WMH),
also called white matter lesions or leukoaraiosis (Wardlaw et al., 2013),
are divided into periventricular (PWMH) and deep (DWMH) (De Groot
et al., 2002; Kim et al., 2008). This distinction is at the base of most
visual rating scales used in clinical settings (Fazekas et al., 1987;
Scheltens et al., 1993) and seems to reflect different functional,
histopathological, and aetiological features (Debette and Markus,
2010; Kim et al., 2008). However, the anatomical definition of the
two classes is somewhat arbitrary (Barkhof and Scheltens, 2006;
DeCarli et al., 2005; Sachdev and Wen, 2005) and varies across
studies, potentially contributing to inconsistencies in results and
making comparisons difficult.
Among the criteria used to define PWMH and DWMH, one widely
accepted measurement follows the “continuity to ventricle” rule,
according to which PWMH are WMH contiguous with the margins of
each lateral ventricle, while DWMH are WMH separate from the
ventricles (Fazekas et al., 1987; Fazekas et al., 1993; van den Heuvel
et al., 2006). Other criteria use the distance from the ventricles to
define the two classes, defining PWMH as WMH within an arbitrary
distance from the ventricle surface, most frequently 10 mm (DeCarli
et al., 2005), or an empirical distance (Wen and Sachdev, 2004).
Another suggested classification further divides WMH into four
categories: juxtaventricular (within 3 mm from the ventricle surface),
periventricular (between 3 and 13 mm), deep and juxtacortical WMHs
(within 4 mm from the corticomedullary junction) (Kim et al., 2008).
To the best of our knowledge, these different criteria adopted to classify
PWMH and DWMH have not been quantitatively compared within a
single analytic setting.
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Kim and colleagues reviewed the differences between PWMH and
DWMH and concluded that they have different functional, histopatho-
logical and aetiological correlates (Kim et al., 2008). They reported a
prevalent link between PWMHs and impaired cognitive performance in
older adults, although this was not consistent across studies
(Bolandzadeh et al., 2012). DWMH seem to be instead preferentially
associated with mood disorders (de Groot et al., 2000; Kim et al., 2008;
Krishnan et al., 2006). Postmortem studies showed that PWMH have
discontinuous ependyma (and therefore high extracellular fluid con-
tent), gliosis, loosening of the white matter fibers, and myelin loss.
DWMH show more axonal loss, vacuolation and increased tissue loss in
more severe lesions, suggesting infarction, in addition to demyelination
and gliosis (Kim et al., 2008; Schmidt et al., 2011; Wardlaw et al.,
2015). Since there are only few pathology studies, the use of neuroima-
ging methods such as diffusion tensor imaging (DTI) MRI offers the
potential of detecting in vivomicrostructural changes in the integrity of
the brain's white matter (Wardlaw et al., 2015). In fact, it has been
shown that PWMH have increased axial diffusivity (AD) and radial
diffusivity (RD) relative to normal appearing WM (Bastin et al., 2009).
However, they did not include DWMH in their evaluation.
Furthermore, PWMHs and DWMHs have been associated with differ-
ent cardiovascular risk factors suggesting at least partially distinct
pathogenic mechanisms. In their review, Kim and colleagues (Kim
et al., 2008) concluded that smooth PWMH may be linked to the
increase of interstitial fluid (cerebrospinal fluid leakage), irregular
PWMH are more likely determined by chronic hemodynamic insuffi-
ciency (hypoperfusion), whereas DWMH may be more attributed to
small vessel disease.
All these associations support the notion that the subdivision into
PWMH and DWMH is clinically relevant. However, there is currently
no objective, unambiguous and non-disputable approach to sharply
divide PWMH and DWMH (Barkhof and Scheltens, 2006; DeCarli
et al., 2005; Sachdev and Wen, 2005).
The aim of our study was twofold: first, to quantitatively compare
the most common criteria used in the literature for the classification of
PWMH and DWMH by estimating differences in respective resulting
WMH volumes; second, to replicate previously reported associations
between WMH and cognitive correlates, tissue microstructure (using
DTI-derived metrics) and cardiovascular risk factors (potentially
involved in WMH aetiology). Specifically, we analysed how associations
with these cognitive, microstructural and clinical correlates (cardio-
vascular risk factors) were influenced by the different classification
criteria, with a view to establishing the most robust method of
differentiating PWMH from DWMH. Ultimately, we aim to understand
the cause of possible contrasting results in the literature and give
further insight into the potential clinical utility of WMH sub-classifica-
tions.
We performed this quantitative evaluation of the cognitive, micro-
structural and clinical correlates of PWMH and DWMH on the
Whitehall imaging sub-study cohort (Filippini et al., 2014), which
represents an ideal sample for the different aims of this study due to
the richness of imaging and non-imaging data.
Methods
Subjects and MRI data acquisition
The sample was drawn from 563 participants recruited to take part
in the Whitehall II Imaging Sub-Study between April 2012 and
December 2014 (Filippini et al., 2014). The Whitehall II Study is a
prospective occupational cohort study established in 1985 (Marmot
and Brunner, 2005). Ethical approval was obtained from the University
of Oxford Central University Research Ethics Committee, and the UCL
Medical School Committee on the Ethics of Human Research.
Informed written consent was obtained from all participants.
Thirty seven subjects were excluded: 14 because of the presence of
major lesions (tumours or major strokes), diagnosis of multiple
sclerosis or hydrocephalus, and 24 because of incomplete MRI scans
or the presence of excessive motion or other artefacts in the images.
Data from the remaining 525 subjects (mean age 69.58 ± 5.33 years)
entered into subsequent analyses.
MRI data were acquired at the Oxford Centre for Functional MRI of
the Brain (FMRIB) using a 3-Tesla, Siemens Magnetom Verio scanner
with 32-channel head coil. Details of acquisition sequences and pre-
processing have been described previously (Filippini et al., 2014). In
this study we used high-resolution T1 images, FLAIR images and
diffusion weighted images, in particular the DTI-derived maps of
fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity
(AD) and radial diffusivity (RD), generated by fitting a diffusion tensor
model at each voxel.
Segmentation of WMH and PWMH/DWMH classification criteria
WMH were automatically segmented on FLAIR images with a
newly developed tool, BIANCA (Brain Intensity AbNormality
Classification Algorithm), a fully-automated, supervised method for
WMH detection, based on the k-nearest neighbour algorithm (Griffanti
et al., 2016). Briefly, BIANCA classifies the image voxels based on their
intensity and spatial features, where the intensity features were
extracted from FLAIR, T1 and FA images (additional options used:
local average intensity within a kernel of size = 3 voxels; MNI
coordinates as spatial features, with a weighting factor of 2; 24
manually segmented images as training dataset). The output image
represents the probability per voxel of being WMH. The WMH maps
used for further analyses in this work included voxels exceeding a
probability of 0.9 of being WMH and located within a white matter
mask automatically generated from T1-weighted images, excluding
cortical grey matter, cerebellum, brainstem and subcortical structures
(see Griffanti et al., 2016 for further details). The WMH map would
also include the possible small hyperintense rim around infarct-like
lesions (lacunes) (Wardlaw et al., 2013).
In order to apply the sub-classification criteria, lateral ventricles
were segmented from T1 images. Tissue segmentation was performed
with FSL-FAST, then ventricles were extracted from the cerebrospinal
fluid (CSF) map as the clusters with the greatest overlap with a
registered and dilated version of the lateral ventricles of the Harvard-
Oxford atlas. The obtained ventricles mask was then registered in
FLAIR space.
WMH were then further sub-classified into PWMH and DWMH
and the relative volumes were calculated according to the following 4
criteria (Fig. 1):
1. Continuity to ventricles (Fazekas et al., 1987; Fazekas et al., 1993;
van den Heuvel et al., 2006): a WMH adjacent to the ventricle
surface is PWMH, otherwise it is DWMH. Each cluster in the WMH
map was considered PWMH if it was, at least partially, overlapping
with a dilated version of the ventricles mask.
2. 10 mm distance (DeCarli et al., 2005): a WMH less than 10 mm
distance from the ventricles is PWMH, otherwise it is DWMH. Each
voxel in the WMH map was considered PWMH if it was within 10
mm distance from the ventricles (calculated as the geometrical
distance from the ventricle mask using the FSL command distance-
map).
3. 3–13 mm distance (Kim et al., 2008): a lesion less than 3 mm from
the ventricles is classified as juxtaventricular; a lesion between 3 and
13mm distance from the ventricles is periventricular, otherwise it is
DWMH. Since BIANCA is not currently optimized to detect juxta-
cortical WMH, this further sub-classification of DWMH was not
performed.
4. Empirical distance: Wen and Sachdev (Wen and Sachdev, 2004)
defined the periventricular region empirically. After manually mea-
suring the width of the rims and caps in 477 healthy 60- to 64-year-
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old individuals, they plotted the values and defined the periventri-
cular width for the rims, anterior and posterior caps as the width
that included 95% of the sample. The resulting map of their study
was used to extract PWMH and DWMH in our study, by registering
the map to the single subject's space and extracting the values for the
two WMH classes.
The resulting volumes of PWMH and DWMH were log-transformed
and entered into subsequent analyses. The comparison of the volumes
across the four criteria was performed using a one-way ANOVA for
repeated measures with post-hoc Bonferroni correction for multiple
comparisons.
Cognitive, microstructural and clinical correlates of PWMH/DWMH
The following measures, collected at the time of the MRI scan, were
selected as indices of executive function, processing speed, and memory, in
line with (Bolandzadeh et al., 2012): Hopkins Verbal Learning Test (HVLT,
immediate and delayed recall), Trail Making Test (TMT), letter and
category fluencies, Boston Naming-60, digit span forward, backward and
sequence, digit symbol and digit coding. For details about the tests used,
please refer to (Filippini et al., 2014). These measures were entered into a
regression analysis as possible predictors of PWMH and DWMH volumes
(dependent variable). The model also included sex, education (number of
years of uninterrupted full time education) and total brain volume
(calculated as the sum of white matter, grey matter and CSF volumes
derived from tissue segmentation using FSL-FAST) as covariates, while age
was included among the potential risk factors (however, for completeness,
we also repeated the analyses with age as covariate). All independent
variables were entered into the model at the same time (enter method or
forced entry).
To test the association with mood disorders, volumes of PWMH and
DWMH were correlated with current depressive symptoms, measured
at the time of the MRI scan using the Centre for Epidemiological
Studies Depression Scale (CES-D), a clinically validated self-report
questionnaire. 524 participants (the CES-D score was missing for one
subject) were categorized into control and sub-threshold depression
groups based on their CES-D scores (score greater than 10 was used to
define sub-threshold depression, as in (Allan et al., 2016; Tudorascu
et al., 2014)) and the volumes of PWMH and DWMH were compared
between the two groups using an independent t-test. The CES-D score
was also considered as a continuous variable across all participants and
correlated with PWMH and DWMH volumes (correcting for age, sex,
and total brain volume).
In the absence of histopathological data, we studied WMH micro-
structure using DTI-derived measures. Accordingly, we compared
PWMH and DWMH in terms of average FA, MD, AD, RD within the
WMH using paired t-tests (or one-way ANOVA for repeated measures
with post-hoc Bonferroni correction for criterion 3) to evaluate
potential differences in underlying microstructure between PWMH
and DWMH.
Finally, to test the link between WMH and cardiovascular risk
factors, we performed a regression analysis including age, Framingham
stroke 10-year percentage risk (i.e. the probability of stroke in the next
10 years, calculated from age, sex, smoking habits, diabetes mellitus,
systolic blood pressure, prior cardiovascular disease, atrial fibrillation,
left ventricular hypertrophy and use of hypertensive medications
(D'Agostino et al., 1994)), mean arterial pressure (MAP, calculated as
(systolic blood pressure + 2*diastolic blood pressure)/3), and body
mass index (BMI). The model included sex and total brain volume as
covariates. All independent variables entered in the model at the same
time.
Fig. 1. Example of WMH sub-classification obtained with the four criteria compared in this study (see main text for details). Legend: JWMH = juxtaventricular white matter
hyperintensities; PWMH = periventricular white matter hyperintensities; DWMH = deep white matter hyperintensities.
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All the tests were repeated using the four classification criteria
described above.
Results
Summary descriptive statistics (mean, standard deviation and
range) of the sample characteristics are reported in Table 1, while
supplementary Figure S1 illustrates the spatial distribution of WMH in
the sample.
Fig. 2 shows the volumes calculated with different criteria (see
Table 1 for details). The repeated measures ANOVA determined that
PWMH and DWMH volumes differ significantly among criteria
(PWMH: F(1.184, 620.386) = 1404.663, p < 0.001; DWMH: F(2.092,
1096.122) = 258.717, p < 0.001). Post-hoc tests using Bonferroni
correction revealed that DWMH calculated with the continuity to
ventricles rule and the 10 mm distance rule are comparable, while
other volumes are significantly different across criteria (see supple-
mentary Table S1 for details). The 3–13 mm distance rule was different
from the other methods by definition, but the differences with respect
to the other criteria remained significant also when considering JWMH
and PWMH together.
Results of the regression analysis exploring the functional corre-
lates of WMH are reported in Table 2. A significant model emerged for
PWMH (and JWMH) regardless of which criterion was used. Among
the functional measures, Digit Span forward was a significant predictor
variable for PWMH (with criteria 1,2,4) and JWMH. The Trail Making
Test was an additional significant predictor for JWMH. For DWMH,
only the empirical distance rule yielded a significant model in which
only total brain volume was a significant predictor for DWMH.
Among the covariates, brain volume was the only significant
Table 1
Sample characteristics.
Descriptive Statistics N Minimum Maximum Mean Std. Dev.
Demographic
Age [years] 525 60.30 83.00 69.58 5.33
Sex [M:F] 424:101
Education [years] 525 6 23 14.03 3.08
Functional correlates (cognition and mood)
Letter fluency 525 3 31 15.75 4.55
Categorical fluency 525 3 40 22.11 5.63
TMT A 523 13 125 30.74 11.91
TMT B 522 24 321 67.98 36.36
TMT B-A 518 0 253 37.74 30.93
Boston Naming-60 525 15 60 57.27 4.49
HVLT immediate recall 525 10 36 27.51 4.74
HVLT delayed recall 525 0 12 9.27 2.68
Digit Span Forward 525 5 16 10.98 2.28
Digit Span Backward 525 4 16 9.76 2.54
Digit Span Sequence 525 0 16 10.12 2.49
Digit Symbol Total 525 13 46 30.86 5.82
Digit Coding 524 13 112 62.44 13.31
CES-D total score 524 0 39 5.23 6.14
Sub-threshold depression (CES-D > 10) [NO:YES] 441:84
Cardiovascular risk factors
MAP 522 68.33 146.67 97.80 11.70
BMI 525 14.30 42.40 26.20 4.19
Framingham 10-years risk score 525 2 84 11.60 8.31
MRI measures
Total brain volume [mm3] 525 1023552.00 1927776.00 1441226.86 129398.90
Total WMH volume [mm3] 525 1103.91 26085.64 5972.62 3850.15
WMH sub-classes volumes [mm3]
P(1) 525 576.60 25394.94 4737.78 3585.96
D(1) 525 122.41 7330.79 1234.84 1059.45
P(2) 525 710.09 23885.03 4691.42 3160.19
D(2) 525 58.71 13013.74 1281.19 1290.78
J(3) 525 521.77 8462.95 2780.68 1278.37
P(3) 525 146.23 19237.30 2231.91 2512.92
D(3) 525 28.80 9327.02 960.03 955.41
P(4) 525 670.21 22123.10 4418.52 2943.56
D(4) 525 125.73 11459.52 1554.09 1381.40
Legend: TMT = Trail Making Test; HLVT = Hopkins Verbal Learning Test; CES-D = Centre for Epidemiological Studies Depression Scale; MAP = mean arterial pressure; BMI = body
mass index; WMH = white matter hyperintensities; P = PWMH volume; J = JWMH volume; D = DWMH volume; 1–4: criteria described in the methods section.
Fig. 2. Comparison of currently used criteria to classify PWMH and DWMH. Boxplot of
volumes for PWMH (P), JWMH (J) and DWMH (D), calculated with the four criteria
described in the methods section.
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Table 2
Functional correlates of WMH. Regression analysis results.
Volume Model Significant predictors
F(14,503) p-value Adjusted R square
P(1) 5.716 < 0.001 0.113 DS forward p=0.012, beta=−0.127
total brain volume p < 0.001, beta=0.309
P(2) 5.997 < 0.001 0.119 DS forward p=0.011, beta=−0.127
(DCOD) (p=0.069, beta=−0.100)
total brain volume p < 0.001, beta=0.307
J(3) 8.236 < 0.001 0.164 TMT A p=0.019, beta=0.121
DS forward p=0.002, beta=−0.148
total brain volume p < 0.001, beta=0.382
P(3) 2.933 < 0.001 0.050 (DCOD) (p=0.057, beta=−0.108)
total brain volume p < 0.001, beta=0.190
P(4) 5.189 < 0.001 0.102 DS forward p=0.017, beta=−0.120
total brain volume p < 0.001, beta=0.284
D(4) 2.388 0.003 0.036 total brain volume p < 0.001, beta=0.243
(sex) (p= 0.068, beta=−0.095)
Factors included in the model: Hopkins Verbal Learning Test (HVLT, immediate and delayed recall), Trail Making Test (TMT A, B and B-A), Letter fluency, category fluencies, Boston
Naming-60, Digit span (DS) forward, backwards and sequence, Digit symbol and Digit coding (DCOD), total brain volume, sex, education. Legend: P = PWMH volume; J = JWMH
volume; D = DWMH volume; 1–4: criteria described in the methods section. Predictors showing a trend of significance (0.05 < p < 0.07) are reported in brackets.
Fig. 3. Microstructural characteristics of PWMH and DWMH. The boxplots show DTI-derived measures calculated within PWMH (P), JWMH (J) and DWMH (D), using the four
criteria described in the methods section.
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predictor. Including age in the model did not alter the relationships
between functional correlates and PWMH and DWMH (the model
remained significant for PWMH with all criteria, for JWMH, and for
DWMH only with the empirical distance rule).
There were no significant differences between the control and sub-
threshold depression groups in PWMH or DWMH volumes calculated
with any criterion. Also the correlation between WMH volumes and
CES-D score was not significant (details are reported in supplementary
Table S2).
Fig. 3 shows the results of the comparison between the WMH sub-
classes in terms of DTI-derived measures. When using any of the 2-
class criteria (i.e. (1) continuity to ventricles, (2) 10 mm and (4)
empirical distance), the PWMH showed significantly lower FA, and
higher MD, AD and RD than DWMH (p < 0.001, with any criterion for
all measures). When using the 3–13 mm distance rule (3) leading to
three WMH sub-classes, the JWMH had significantly lower FA than
PWMH (pcorr < 0.001), which had lower FA than DWMH (pcorr <
0.001), suggesting that FA increases with the distance from the
ventricles (JWMH < PWMH < DWMH). When testing the other
DTI-derived measures, JWMH showed significantly higher MD, AD
and RD values relative to DWMH and PWMH (pcorr < 0.001, for all
comparisons). PWMH and DWMH were more similar, although
PWMH had significantly lower MD (pcorr=0.001), AD (pcorr=0.001),
and RD (pcorr=0.004) than DWMH (JWMH > > DWMH > PWMH).
Results of the regression analyses exploring association with
cardiovascular risk factors are reported in Table 3. Using the enter
method, a significant model emerged both for PWMH (and JWMH)
and for DWMH, calculated with all of the four criteria, but the
significant predictor variables were different for the two classes.
Mean arterial pressure was a significant predictor for PWMH with all
criteria and for JWMH, but for DWMH only with the empirical
distance criterion. On the other hand, body mass index was significant
predictor for DWMH, but for PWMH only with the 3-class criterion.
Age was a significant predictor for PWMH (and JWMH) calculated
with all the criteria (p < 0.001) and for DWMH calculated with the
empirical distance rule (p=0.001), but the effect size (beta) was higher
for PWMH than for DWMH. Among the covariates, brain volume was a
significant predictor in all models except for D(1), while sex was
significant predictor for P(2), J(3) and P(4).
Discussion
In this study we compared the most widely used criteria for the
quantification of PWMH and DWMH and examined functional,
microstructural and clinical correlates of the two WMH sub-classes.
This was done with the ultimate aim of helping to compare studies,
replicate previous results, and understand the cause of possible
contrasting results in the literature.
When comparing the WMH volumes calculated with four criteria
for classification of PWMH and DWMH, our results showed that the
continuity to ventricles and 10 mm distance rules give the most similar
results in terms of WMH volume quantification. These are the two most
widely used criteria in the literature, not only in volumetric methods
for WMH measurement but also in visual rating scales. Our results
suggest that studies using either of the two methods should be
comparable. However, it needs to be kept in mind that, when using
Table 3
Clinical correlates of WMH. Regression analysis results.
Volume Model Significant predictors
F(6,515) p-value Adjusted R
square
P(1) 25.071 < 0.001 0.217 MAP p=0.012, beta=0.108
Age p < 0.001, beta=0.354
total brain volume p < 0.001, beta=0.289
(sex) (p=0.055, beta=−0.088)
D(1) 2.488 0.022 0.017 BMI p=0.004, beta=0.131
P(2) 26.628 < 0.001 0.228 MAP p=0.009, beta=0.113
Age p < 0.001, beta=0.363
total brain volume p < 0.001, beta=0.286
sex p=0.040, beta=−0.093
D(2) 3.889 0.001 0.032 BMI p=0.008, beta=0.118
(Age) (p=0.060, beta=0.100)
total brain volume p=0.009, beta=0.131
J(3) 28.068 < 0.001 0.238 MAP p=0.021, beta=0.098
Age p < 0.001, beta=0.319
total brain volume p < 0.001, beta=0.368
sex p=0.030, beta=−0.098
P(3) 16.555 < 0.001 0.152 MAP p=0.018, beta=0.106
BMI p=0.049, beta=0.082
Age p < 0.001, beta=0.330
total brain volume p < 0.001, beta=0.167
D(3) 3.173 0.005 0.024 BMI p=0.031, beta=0.096
Framingham p=0.035, beta=−0.122
total brain volume p=0.015, beta=0.123
P(4) 23.215 < 0.001 0.204 MAP p=0.007, beta=0.116
Age p < 0.001, beta=0.351
total brain volume p < 0.001, beta=0.267
sex p=0.026, beta=−0.103
D(4) 9.477 < 0.001 0.089 BMI p < 0.001, beta=0.164
MAP p=0.046, beta=0.093
Age p=0.001, beta=0.175
total brain volume p < 0.001, beta=0.216
Factors included in the model: Framingham score, age, mean arterial pressure (MAP), body mass index (BMI), sex, total brain volume. Legend: P = PWMH volume; J = JWMH volume;
D = DWMH volume; 1–4: criteria described in the methods section. Predictors showing a trend of significance (0.05 < p < 0.07) are reported in brackets.
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visual rating scales, the intra-rater variability is still a source of
heterogeneity in WMH quantification. When quantifying the WMH
load in terms of volumes, the 10 mm distance rule should be more
suitable for automatic implementation, since confluent lesions that are
touching the ventricles but expanding in the deep WM would be
probably considered as separate entities by a human rater, even when
adopting the continuity to ventricles rule.
Using the map created with the empirical distance rule we obtained
significantly smaller volumes of PWMH (and higher DWMH) com-
pared to the other (2-class) methods. This difference suggests that this
criterion might be sample specific and using this rule might lead to
results that are not comparable across studies.
In agreement with literature (Bolandzadeh et al., 2012; Kim et al.,
2008), we found PWMH, but not DWMH, to be associated with
impaired cognitive function. This result seems to remain consistent
despite different MRI sequences, WMH quantification methods, and
neuropsychological batteries used. In particular, the PWMH were
associated with working memory. This is in line with the notion that
executive functions rely on long distance connections in the white
matter, which are more likely to be disrupted by PWMH. In contrast,
DWMH are believed to primarily disrupt short connections
(Bolandzadeh et al., 2012).
We did not find differences between controls and sub-threshold
depression groups, nor significant correlation between WMH volumes
and CES-D score, as a measure of mood disorders (de Groot et al.,
2000; Krishnan et al., 2006). This could be due to the fact that the
variability in our sample is quite low, with very few subjects showing
depression symptoms (i.e. only 38 out of 524 participants scored more
than 16).
The DTI findings suggest that WMH classes have different under-
lying microstructural properties. When using any of the two-class
criteria, PWMH showed significantly decreased FA and increased MD,
AD and RD with respect to DWMH, supporting the neuropathological
observation that PWMH are characterized by gliosis, loosening of the
white matter fibers, and myelin loss. DWMH instead are more
heterogeneous and may present less gliosis, but more axonal loss,
vacuolisation and arteriolosclerosis (Wharton et al., 2015). When
further subdividing into 3 classes, JWMH had the lowest FA and
highest MD, AD and RD with a significant difference from PWMH,
suggesting that the microstructure in closer proximity to the ventricles
is substantially different in nature from parenchymal WMH, possibly
reflecting subependimal gliosis (Kim et al., 2008; Wharton et al., 2015).
With this criterion, the DWMH had greater mean magnitude of water
diffusion (higher MD), possibly representing greater axonal (higher
AD) and myelin (higher RD) damage, than PWMH. These differences
may be explained by the fact that PWMH are characterized by more
microgliosis, which may selectively “pseudo-normalise” MD. Further
studies should explore the above hypotheses in more detail and clarify
whether the first lining around the ventricles should not even be
considered WMH of vascular origin.
We also found that PWMH and DWMH have distinct associations
with cardiovascular risk factors, suggesting that they may have
different aetiology. More precisely, PWMH were significantly asso-
ciated with arterial pressure but not with BMI. On the contrary,
DWMH were associated with BMI but not with arterial pressure.
This dissociation is difficult to interpret in light of previous pathology
studies that have hypothesized that deep WMH changes (DWMH)
present more hypoxic/ischemic damage whereas periventricular
changes may have a greater inflammatory/metabolic component
(Fazekas et al., 1993; Fernando et al., 2006). Since we only had a
limited set of cardiovascular risk factors to be entered in the model, our
findings should be interpreted cautiously and prompt further studies,
which we hope will benefit from the methodological suggestions of
the present study. Age was a significant predictor mainly for PWMH,
in line with studies suggesting that PWMH are specifically linked to
age-related neurodegenerative processes.
The finding that total brain volume was a significant predictor of
both PWMH and DWMH suggests that is important to take into
account brain size when quantifying WMH, as it may influence the
associations of interest. This can be done, for example, by adding brain
volume as a covariate or normalizing the volumes.
Taken together, these results confirm that the two WMH classes are
uniquely associated with different cognitive abilities, imaging biomar-
kers and risk factors, suggesting that their distinction is clinically valid
and that they may represent useful and distinct imaging biomarkers.
However, longitudinal studies are needed to further explore the
differential evolution overtime of the two WMH classes and their
relevance to clinical variables and risk factors. In addition, since all
classification criteria currently used in the literature are somewhat
arbitrary (Barkhof and Scheltens, 2006; DeCarli et al., 2005; Sachdev
and Wen, 2005), data-driven approaches should be used to explore
whether other rules better separate the two classes according to specific
clinical correlates of interest. For example, the distance from the
ventricles that better separates the two classes could vary depending
on the clinical variable of interest and be adapted according to brain
size. Related to this, it should be noted that the dichotomization into
PWMH and DWMH was first introduced in visual rating scales, to
provide a more fine-grained quantification of the WMH load. The
current increasing availability of automated segmentation algorithms
for detailed mapping of WMH at the voxel-level will allow the study of
the relationship with clinical variables in more detail, possibly repla-
cing the current hard dichotomization with a continuous distribution
(Barkhof and Scheltens, 2006; Griffanti et al., 2016; Rostrup et al.,
2012).
In conclusion, our study suggests that the classification criterion
used for the definition of PWMH and DWMH is not a major obstacle
for the comparison of different studies. Among them, the 10 mm
distance rule should give the most comparable results to the current
literature in terms of volumes and showed the best separation between
PWMH and DWMH in terms of association with the factors tested in
this study. Our findings that PWMH and DWMH have different
functional, microstructural and clinical correlates further support the
hypothesis that they are indeed different entities and that their
distinction can provide useful information about healthy and patholo-
gical aging processes.
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